University Health Network, Toronto: clinical-trial pipeline
University Health Network, Toronto is the sponsor of 1,432 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 364 are not yet finished and 12 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 906 |
| Phase 2 | 226 |
| Phase 4 | 80 |
| Phase 3 | 72 |
| Phase 1 | 71 |
| Phase 1/2 | 43 |
| Phase 2/3 | 25 |
| Early phase 1 | 9 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 724 |
| Recruiting | 211 |
| Unknown | 210 |
| Active, not recruiting | 111 |
| Terminated | 89 |
| Not yet recruiting | 42 |
| Withdrawn or not authorised | 42 |
| Suspended or halted | 3 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 645 |
| Nephrology and urology | 171 |
| Cardiovascular | 166 |
| Gastroenterology and liver | 118 |
| Neurology | 112 |
| Infectious disease and vaccines | 95 |
| Metabolic and endocrine (diabetes, obesity) | 75 |
| Women's health and obstetrics | 73 |
| Immunology and rheumatology | 72 |
| Rare and genetic diseases | 61 |
| Psychiatry and mental health | 56 |
| Musculoskeletal | 54 |
Countries
| Country | Trials |
|---|---|
| Canada | 1,360 |
| United States | 26 |
| Australia | 9 |
| Spain | 8 |
| Italy | 7 |
| Brazil | 5 |
| United Kingdom | 4 |
| Singapore | 4 |
| Hong Kong SAR China | 3 |
| Malaysia | 3 |
| New Zealand | 3 |
| Austria | 2 |
| Colombia | 2 |
| Netherlands | 2 |
| Uganda | 2 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-22 | New trial posted | Optimizing Response to Immunotherapy With Online Adaptive Pulsed Radiotherapy in Incurabl… |
| 2026-10-21 | New trial posted | AI-SC Multi-center Study |
| 2026-10-20 | New trial posted | SALI-10 Probiotic to Reduce Osteoradionecrosis and Dental Toxicity Following Radiation Th… |
| 2026-10-20 | New trial posted | Prophylaxis for Emetogenic radioTherapy With Akynzeo |
| 2026-10-01 | New trial posted | miRNA to Guide Appropriate Intervention of Small Testis Masses |
| 2026-09-29 | New trial posted | Effects of Excitatory and Inhibitory LIFUS of GPi in Parkinsonian Patients Without DBS |
| 2026-09-25 | New trial posted | Phase II Study of CAmizestrant in Resectable Endometrial Adenocarcinoma |
| 2026-09-22 | New trial posted | Study of Pregnancy in Patients With Myeloproliferative Neoplasms |
| 2026-09-21 | New trial posted | Echocardiographic Perspectives on Transient Mitral Regurgitation After Septal Myectomy |
| 2026-09-15 | New trial posted | Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients W… |
| 2026-09-14 | New trial posted | Co-Adaptation of an Digital Pain Management Program for Canadian Veterans |
| 2026-09-14 | New trial posted | Vagina-View Safety and Imaging Feasibility |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05440864 | Durvalumab and Tremelimumab in Resectable HCC | Phase 2 | Active, not recruiting | Canada, Spain, Italy |
| NCT03569826 | Canadian Network for Autoimmune Liver Disease | Not applicable | Recruiting | Canada |
| NCT07189377 | Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors | Phase 4 | Recruiting | Canada |
| NCT07064954 | Autologous Cold-stored Apheresis Platelets | Phase 2/3 | Recruiting | Canada |
| NCT05843188 | Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer | Phase 2 | Active, not recruiting | Canada |
| NCT07852871 | miRNA to Guide Appropriate Intervention of Small Testis Masses | Not applicable | Recruiting | Canada |
| NCT05503290 | The Lullaby Project as a Musical Intervention for Pregnant Individuals With Epilepsy | Not applicable | Recruiting | Canada |
| NCT00890006 | Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (… | Not applicable | Active, not recruiting | Canada |
| NCT06227520 | Acellular Dermal Allograft for Chronic Diabetic Wounds | Not applicable | Not yet recruiting | Canada |
| NCT07538401 | ASCiminib, With or Without Dasatinib Combination, as a 2nd-Line Therapy to ADVANCE the Treatment for Chronic… | Phase 2 | Not yet recruiting | |
| NCT06668454 | Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol) | Not applicable | Recruiting | Canada |
| NCT06050707 | MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach | Phase 2 | Recruiting | Australia, Canada, United States |
| NCT06987682 | Stimulating Postural Control to Augment Rehabilitation After Cerebral Stroke (SPARC): a Pilot Trial | Not applicable | Recruiting | Canada |
| NCT06335914 | Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer | Not applicable | Recruiting | Canada |
| NCT07242053 | Margin Intraoperative CT Feedback Feedback Study | Not applicable | Active, not recruiting | Canada |
| NCT05350540 | Hypopharynx ICG to Reduce the Fistula Rate in Patients Undergoing Salvage Laryngectomy | Phase 2 | Recruiting | Canada |
| NCT03358303 | Effects of Telemonitoring on the Outcome of Heart Failure Patients After an Incidence of Acute Decompensation | Not applicable | Active, not recruiting | Canada |
| NCT03650595 | MRI Guided Focal Laser Ablation of Prostate Cancer | Not applicable | Recruiting | Canada |
| NCT07580456 | AI for Gastric POCUS ( Point-of-care Ultrasound) | Not applicable | Recruiting | Canada |
| NCT06142773 | Study to Investigate an Association Between Brain Activity and Tidal Volume in Humans (BATMAN) | Not applicable | Recruiting | Canada |
| NCT07528547 | Hypersight and Ethos In Pediatric Radiotherapy | Not applicable | Recruiting | Canada |
| NCT04901884 | PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation | Not applicable | Recruiting | Canada |
| NCT07885007 | AI-SC Multi-center Study | Not applicable | Active, not recruiting | Canada |
| NCT05497219 | Reference Values for Videofluoroscopic Measures of Swallowing | Not applicable | Recruiting | Canada, United States |
| NCT06831032 | Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response | Not applicable | Recruiting | Canada |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "University Health Network, Toronto clinical trials: 364 open, 97 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/university-health-network-toronto/, data as of 2026-10-25.